basophil stimulation buffer (bsb (Becton Dickinson)
Structured Review
Basophil Stimulation Buffer (Bsb, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stimulating+buffer/basophil+stimulation+buffer++bsb/pm28442583-132-25-32
Average 90 stars, based on 1 article reviews
Images
Related Articles
Degranulation Assay:Article Title: Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ . Article Snippet: For detection of the level of B-cell activation, samples were stained for CD19 (1:300 dilution of anti-human CD19 APC; BD Biosciences, Oxford, UK) and CD69 (1:300 dilution of antihuman CD69 PE; BD Biosciences, Oxford, UK) and/or the corresponding Article Title: Serum induced CD63 and CD203c activation tests in chronic urticaria Article Snippet: Background: Approximately half of patients with chronic urticaria (CU) have functional autoantibodies against FceRIα or against IgE that induce histamine release from basophils and cutaneous mast cells.. In addition to intracutaneous autologous serum skin test (ASST), more recently upregulation of CD63 and CD203c molecules on basophils has been proposed to detect the presence of autoantibodies in sera of CU patients.. Objective: Our aim was to assess the effect of serum from CU patients on basophil CD63 and CD203c expression and to correlate serum-induced basophil activation with ASST. Incubation:Article Title: Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ . Article Snippet: For detection of the level of B-cell activation, samples were stained for CD19 (1:300 dilution of anti-human CD19 APC; BD Biosciences, Oxford, UK) and CD69 (1:300 dilution of antihuman CD69 PE; BD Biosciences, Oxford, UK) and/or the corresponding Article Title: Serum induced CD63 and CD203c activation tests in chronic urticaria Article Snippet: Background: Approximately half of patients with chronic urticaria (CU) have functional autoantibodies against FceRIα or against IgE that induce histamine release from basophils and cutaneous mast cells.. In addition to intracutaneous autologous serum skin test (ASST), more recently upregulation of CD63 and CD203c molecules on basophils has been proposed to detect the presence of autoantibodies in sera of CU patients.. Objective: Our aim was to assess the effect of serum from CU patients on basophil CD63 and CD203c expression and to correlate serum-induced basophil activation with ASST. Binding Assay:Article Title: Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ . Article Snippet: For detection of the level of B-cell activation, samples were stained for CD19 (1:300 dilution of anti-human CD19 APC; BD Biosciences, Oxford, UK) and CD69 (1:300 dilution of antihuman CD69 PE; BD Biosciences, Oxford, UK) and/or the corresponding Article Title: Serum induced CD63 and CD203c activation tests in chronic urticaria Article Snippet: Background: Approximately half of patients with chronic urticaria (CU) have functional autoantibodies against FceRIα or against IgE that induce histamine release from basophils and cutaneous mast cells.. In addition to intracutaneous autologous serum skin test (ASST), more recently upregulation of CD63 and CD203c molecules on basophils has been proposed to detect the presence of autoantibodies in sera of CU patients.. Objective: Our aim was to assess the effect of serum from CU patients on basophil CD63 and CD203c expression and to correlate serum-induced basophil activation with ASST. Positive Control:Article Title: Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K δ . Article Snippet: For detection of the level of B-cell activation, samples were stained for CD19 (1:300 dilution of anti-human CD19 APC; BD Biosciences, Oxford, UK) and CD69 (1:300 dilution of antihuman CD69 PE; BD Biosciences, Oxford, UK) and/or the corresponding Article Title: Serum induced CD63 and CD203c activation tests in chronic urticaria Article Snippet: Background: Approximately half of patients with chronic urticaria (CU) have functional autoantibodies against FceRIα or against IgE that induce histamine release from basophils and cutaneous mast cells.. In addition to intracutaneous autologous serum skin test (ASST), more recently upregulation of CD63 and CD203c molecules on basophils has been proposed to detect the presence of autoantibodies in sera of CU patients.. Objective: Our aim was to assess the effect of serum from CU patients on basophil CD63 and CD203c expression and to correlate serum-induced basophil activation with ASST. |
